Australia’s new lung cancer screen program further disadvantages Aboriginal and Torres Strait Islander peoples, who are ...

ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

A study shows for the first time the relationship between this disease and the damage caused to DNA by breathing pollution.

At just 52 years old, a woman has been diagnosed with Stage 4 lung cancer. A non-smoker who had worked full-time since age 22, she now faces a terminal illness while trying to support her husband and ...

Lung cancer is Australia’s fifth most diagnosed cancer, but causes the greatest number of deaths because it is often ...

Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

Actress and painter Lee Hye-young, who confessed to her health problems, said she spends most of the exhibition's profits on ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

A lawsuit filed in Wyandotte County claims Harcros Chemicals has been knowingly emitting dangerous quantities of toxins for ...